Brain+ AS (OCSE:BRAINP) EV-to-EBIT : -0.14 (As of May. 20, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Brain+ AS's Enterprise Value is kr2.38 Mil. Brain+ AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-17.49 Mil. Therefore, Brain+ AS's EV-to-EBIT for today is -0.14.

The historical rank and industry rank for Brain+ AS's EV-to-EBIT or its related term are showing as below:

OCSE:BRAINP' s EV-to-EBIT Range Over the Past 10 Years
Min: -6.52 Med: 0 Max: 0
Current: -0.14

OCSE:BRAINP's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 18.15 vs OCSE:BRAINP: -0.14

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Brain+ AS's Enterprise Value for the quarter that ended in Dec. 2023 was kr9.61 Mil. Brain+ AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-17.49 Mil. Brain+ AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -181.98%.

Brain+ AS EV-to-EBIT Historical Data

The historical data trend for Brain+ AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS EV-to-EBIT Chart

Brain+ AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-4.25

-1.85

-0.55

Brain+ AS Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial			-4.25	-	-1.85	-	-0.55

Competitive Comparison of Brain+ AS's EV-to-EBIT

For the Health Information Services subindustry, Brain+ AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brain+ AS's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Brain+ AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Brain+ AS's EV-to-EBIT falls into.

Brain+ AS EV-to-EBIT Calculation

Brain+ AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	2.377	/	-17.486
	=	-0.14

Brain+ AS's current Enterprise Value is kr2.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Brain+ AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-17.49 Mil.

Brain+ AS (OCSE:BRAINP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Brain+ AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-17.486	/	9.6087056
	=	-181.98 %

Brain+ AS's Enterprise Value for the quarter that ended in Dec. 2023 was kr9.61 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Brain+ AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was kr-17.49 Mil.

Brain+ AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Brain+ AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Brain+ AS (OCSE:BRAINP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kobmagergade 53, 3rd Floor, Copenhagen, DNK, DK-1150

Website

https://www.brain-plus.com

Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS (OCSE:BRAINP) Headlines

No Headlines